Sixty days from signature to launch for a rare-disease biologic.

A specialty pharmaceutical manufacturer.

A specialty pharmaceutical manufacturer of a high-cost biologic (approximately $15,000 WAC) for a rare disease required a rapid clinical pathway to patient access. An asynchronous telehealth model, embedded within the manufacturer's direct-to-consumer experience, moved the program from contract signature to live patient flow in sixty days.

With the program operational, ultra-targeted specialty campaigns drove a material increase in patient conversion through the clinical funnel, expanding access to a medication whose cost and distribution constraints had historically slowed prescribing.

Signature to launch
60 days
Therapy
Rare-disease biologic, ~$15K WAC
Result
Increased specialty conversion

Sixty-day direct-to-consumer launch for a lice treatment platform.

A consumer health manufacturer.

A consumer health manufacturer set out to capture a new addressable market: parents managing classroom lice exposures. The opportunity combined speed (reaching live patient flow ahead of school cycles) and ease of access (prescription treatment without a clinic visit).

A direct-to-consumer telehealth program reached live patient flow in under sixty days from contract signature, enabling patients exposed at school to receive evaluation and prescription without scheduling friction and opening a new channel into a previously underserved patient population.

Signature to launch
Under 60 days
Channel
DTC consumer health
Result
New addressable market captured

Telepsychiatry coverage across 25 states with no gaps.

A national behavioral healthcare platform.

A national behavioral healthcare platform needed psychiatric Nurse Practitioners to deliver telemedicine services to patients across twenty-five states, with consistent coverage and no gaps in clinical availability. A network of fifteen experienced psychiatric NPs was assembled and onboarded, credentialed across the required jurisdictions and ready to fill scheduled and on-demand shifts.

With the network in place, the client maintained uninterrupted behavioral healthcare services for patients in every state served, supported by the credentialing and scheduling infrastructure behind the engagement.

States
25
Clinicians
15 psychiatric NPs
Coverage
No gaps reported

Eight years of HIV and STD telemedicine consultations.

A national HIV and STD telemedicine platform.

A national HIV and STD telemedicine platform sought to expand access to consultations and preventive care such as PrEP, particularly across underserved communities in the United States. Over eight years, the engagement has staffed physicians across most U.S. states and supported more than 200,000 telehealth consultations, with the recruitment and placement infrastructure to sustain consistent coverage at scale.

The work materially increased access to consultations and preventive medications, with sustained year-over-year growth in clinical volume and continuity of care.

Duration
Eight years and ongoing
Consultations
200,000+
Reach
Most U.S. states

Statewide telemedicine expansion for a California urgent care chain.

A regional urgent care chain operating across California.

A regional urgent care chain operating brick-and-mortar locations across California sought to extend its service offerings via telemedicine, both broadening patient access and extending the working hours of its clinical brand without adding physical capacity.

The engagement coordinated implementation of the direct-to-patient telemedicine platform, scaled the clinical program from pilot through full launch, fully staffed it across the required shifts, and helped instill the operational protocols that now allow the urgent care chain to deliver consistent virtual care across patient populations.

Geography
California statewide
Scope
Platform, staffing, protocols
Engagement
End-to-end clinical program build

Considering a similar engagement?